Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 796 | 1,245 | 2,403 | 1,045 | 2,554 |
| Marketable Securities | 2,150 | 2,720 | 1,500 | 1,500 | 1,720 |
| Receivables | 1,704 | 1,426 | 497 | 2,390 | 1,336 |
| Inventories | 1,408 | 1,921 | 1,944 | 1,498 | 1,663 |
| Other current assets | 195 | 358 | 2,090 | 1,530 | 1,467 |
| TOTAL | $6,253 | $7,670 | $8,433 | $7,964 | $8,739 |
| Non-Current Assets | |||||
| PPE Net | 3,245 | 3,371 | 4,446 | 4,559 | 4,490 |
| Intangibles | 94 | 94 | 94 | 94 | 94 |
| Other Non-Current Assets | 1,113 | 1,094 | 1,270 | 1,329 | 1,424 |
| TOTAL | $4,452 | $4,559 | $5,810 | $5,983 | $6,009 |
| Total Assets | $10,705 | $12,228 | $14,243 | $13,946 | $14,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 118 | 368 | 1,750 | 1,083 | 1,000 |
| Accounts payable and accrued liabilities | 808 | 775 | 910 | 1,257 | 876 |
| Accrued Expenses | 545 | 398 | 568 | 404 | 626 |
| Other current liabilities | 748 | N/A | N/A | N/A | N/A |
| TOTAL | $4,155 | $5,432 | $9,021 | $5,818 | $3,748 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 917 | 1,167 |
| Deferred Revenues | 764 | 1,013 | 1,501 | 1,908 | 104 |
| Other Non-Current Liabilities | 368 | 337 | 346 | 350 | 0 |
| TOTAL | $611 | $605 | $639 | $1,585 | $2,594 |
| Total Liabilities | $4,766 | $6,037 | $9,660 | $7,403 | $6,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,414 | 14,348 | 14,274 | 14,158 | 13,875 |
| Common Shares | 111,444 | 111,233 | 111,341 | 110,705 | 110,443 |
| Retained earnings | -112,211 | -111,655 | -108,637 | -106,040 | -103,916 |
| Other shareholders' equity | 6,707 | 6,613 | 1,879 | 1,879 | 1,879 |
| TOTAL | $5,939 | $6,192 | $4,583 | $6,543 | $8,406 |
| Total Liabilities And Equity | $10,705 | $12,228 | $14,243 | $13,947 | $14,748 |